EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Structural basis for ligand recognition in the tobramycin riboswitch

Elke Duchardt-Ferner iD, Leon Kraus, Anahita Limouchi, Beatrix Suess iD, Jens Wöhnert iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Elke Duchardt-Ferner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Biosciences and Center of Magnetic Resonance (BMRZ), Goethe-University Frankfurt, Max-von-Laue Straße 9, 60438 Frankfurt, Ger…. Hauptthemen laut MEDLINE: Tobramycin, Riboswitch, Anti-Bacterial Agents. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Biomolecular Magnetic Resonance (BMRZ), DFG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a novel tobramycin-responsive riboswitch was developed by a combination of Capture-SELEX and in vivo screening. This riboswitch regulates translation initiation in eukaryotes with a high dynamic range and remarkable ligand affinity and selectivity. Its secondary structure differs from all previously described aminoglycoside-binding RNA motifs, suggesting a novel mode of ligand recognition. To provide a structural basis for the remarkable regulatory efficiency and ligand selectivity of this riboswitch, we investigated its structure in complex with its cognate ligand tobramycin by high-resolution solution nuclear magnetic resonance spectroscopy. The structure of the complex reveals a novel structural organization for an aminoglycoside binding motif with a unique pattern of intermolecular hydrogen bonds and electrostatic interactions between the RNA and functional groups of all three rings of the ligand. In contrast to other aminoglycoside binding motifs, ligand binding of the tobramycin riboswitch is coupled with the formation of an extensive network of noncanonical RNA–RNA interactions, rationalizing the high ligand affinity of this small hairpin RNA. Comparison with the free form of the RNA shows that the latter is much less compact, lacking many RNA–RNA interactions, in particular in the bulge regions, thereby immediately providing a rationale for the exceptional switching efficiency of this synthetic riboswitch.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TobramycinRiboswitchAnti-Bacterial AgentsLigandsNucleic Acid ConformationModels, MolecularHydrogen BondingBinding Sites

Substanzen

TobramycinRiboswitchLigandsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Institute for Molecular Biosciences and Center of Magnetic Resonance (BMRZ), Goethe-University Frankfurt, Max-von-Laue Straße 9, 60438 Frankfurt, Germany.
  • Department of Biology, Synthetic RNA Biology, TU Darmstadt, Schnittspahnstrasse 10, 64287 Darmstadt, Germany.
  • Centre for Synthetic Biology, TU Darmstadt, 64287 Darmstadt, Germany.

ORCID-Profile: Elke Duchardt-Ferner, Beatrix Suess, Jens Wöhnert

Förderung

  • Deutsche Forschungsgemeinschaft
  • Biomolecular Magnetic Resonance (BMRZ)
  • DFG

Zitieren

APA

Duchardt-Ferner, E., Kraus, L., Limouchi, A., Suess, B., & Wöhnert, J. (2025). Structural basis for ligand recognition in the tobramycin riboswitch. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf817

Vancouver

Duchardt-Ferner E, Kraus L, Limouchi A, Suess B, Wöhnert J. Structural basis for ligand recognition in the tobramycin riboswitch. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf817

BibTeX
@article{DuchardtFerner2025,
  author = {Duchardt-Ferner, Elke and Kraus, Leon and Limouchi, Anahita and Suess, Beatrix and Wöhnert, Jens},
  title = {Structural basis for ligand recognition in the tobramycin riboswitch},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf817}
}
Kostenlos starten →